The long Filamin-A isoform is required for intestinal development and motility: implications for chronic intestinal pseudo-obstruction
Almira Zada(Erasmus MC), Maria M. Alves(Erasmus MC)
Cited by 16
Related Papers
PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis Complex
|Scientific Reports|2015|47
Genetic screening of Congenital Short Bowel Syndrome patients confirms CLMP as the major gene involved in the recessive form of this disorder
|European Journal of Human Genetics|2016|24